Scoop.it

Les moyens digitaux utilisés depuis le début de la crise sanitaire, existent depuis longtemps. Social, consommation, travail, santé, éducation… comment le confinement nous oblige à dématerialiser toutes nos habitudes.

Source: www.ladn.eu

Also: Mercom's Q1 2020 digital health funding report; Fitbit, Scripps, Stanford collaborate on COVID-19 detection research.

Source: www.mobihealthnews.com

Si le nombre de personnes infectées dans la population générale a tendance à baisser, il en est de même chez les professionnels de santé. Dans un communiqué de presse publié ce jour par l’AP-HP, le nombre de professionnels de santé infectés à l’AP-HP est de 3800 le 12 avril. Si ce nombre peur paraitre élevé, il est en forte baisse.

Source: www.whatsupdoc-lemag.fr

French drugmaker Sanofi is collaborating with US start-up Luminostics to develop a smartphone-based self-diagnosis test for COVID-19 that could give a result within 30 minutes.

The two companies say the test would take the form of an iOS or Android smartphone app linked to a plug-in device that could be used by patients on their own, needing no access to a healthcare professional or laboratory.

It could be available before the end of the year, subject to regulatory approvals, they suggest.

San Jose, California-based Luminostics has developed a smartphone-based diagnostic platform that can detect a broad range of substances – bacteria, viruses, small molecules, hormones, and proteins for example – from a variety of sample types.

It uses nanoparticles that bind to their target – in this case SARS-CoV-2 genetic material – and result in a glow-in-the-dark chemical reaction.

The luminescence can be detected using a consumer smartphone’s built-in camera and flash plus a low-cost, reusable plastic adapter as the reader device, with 100 to 1,000-fold lower detection limits than conventional visual assays, according to the company.

Source: pharmaphorum.com